Policy

BIO advocates for laws, funding and other governmental actions that ensure that biotechnology companies are able to focus on their research to drive the future of innovation.

Press Releases

Biotechnology Innovation Organization (BIO) Launches the BIO Investment Council (BIC) to Accelerate Capital Formation

January 7, 2026

WASHINGTON, DC (January 7th, 2026) – Today, the Biotechnology Innovation Organization (BIO) announced the launch of the BIO Investment Council (BIC). The newly established council aims to serve small and emerging biotech innovators by increasing engagement between investors and BIO members to…

BIO Statement on Changes Announced to the U.S. Childhood Vaccine Schedule

January 5, 2026

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on changes announced to the US childhood vaccine schedule.“American health is as unique as America itself. The US vaccination schedule is the result of…

BIO Statement on December 2025 ACIP Meeting

December 5, 2025

WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Head of Health Policy and Programs of the Biotechnology Innovation Organization (BIO) released the following statement on the December 2025 ACIP meeting.“For decades, the CDC’s Advisory Committee on Immunization Practices (ACIP) has…